Last reviewed · How we verify
Tea tree oil vagitories
Tea tree oil vagitories deliver antimicrobial and anti-inflammatory compounds directly to vaginal tissue to treat infections and inflammation.
Tea tree oil vagitories deliver antimicrobial and anti-inflammatory compounds directly to vaginal tissue to treat infections and inflammation. Used for Vaginal infections (bacterial vaginosis, candidiasis, trichomoniasis), Vaginal inflammation and irritation.
At a glance
| Generic name | Tea tree oil vagitories |
|---|---|
| Sponsor | University of Sarajevo |
| Drug class | Herbal antimicrobial vaginal suppository |
| Modality | Small molecule |
| Therapeutic area | Gynecology / Infectious Disease |
| Phase | FDA-approved |
Mechanism of action
Tea tree oil contains terpineol and other volatile compounds with documented antimicrobial activity against bacteria, fungi, and some viruses. When formulated as vaginal suppositories, these compounds are released locally to reduce pathogenic microorganisms and modulate local inflammatory responses. The mechanism is primarily antimicrobial rather than receptor-mediated.
Approved indications
- Vaginal infections (bacterial vaginosis, candidiasis, trichomoniasis)
- Vaginal inflammation and irritation
Common side effects
- Local irritation or burning
- Allergic contact dermatitis
- Vaginal discomfort
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Tea tree oil vagitories CI brief — competitive landscape report
- Tea tree oil vagitories updates RSS · CI watch RSS
- University of Sarajevo portfolio CI